New investor Greatbatch has led the round with a $5m commitment, with the remaining cash coming from existing stakeholders.

The healthcare analytics software startup doubled its funding with a $10m round led by Intel Capital that included existing backer BlueCross BlueShield Venture Partners.

Stem cell company Definigen, a Cambridge spinout, raises $2.3m to launch new pancreatic and lung stem cell products to support predictions of drug candidates before clinical trials.

Texas spinout Decisio Health launches its bedside clinical intelligence platform to support healthcare staff in hospitals following a $4.5m series A round.

The biopharmaceutical company, which has raised about $480m in equity funding from backers including Novo and AbbVie, has floated on Nasdaq.

Abingdon Health enters into a partnership with Sumitomo Chemical to build on the rapid diagnostic test platform developed by Sumitomo and Abingdon Health subsidiary Molecular Vision.

BrightWater Medical, developer of a non-invasive device to treat severe ureteral obstructions, has completed a series A round led by OSF HealthCare.

Advanced radiology startup Zebra Medical Vision will work with the US-based care system to further develop its intelligent imaging analytics technology.